In the present study, we determined the levels of serum FGF23 in a group of nondialyzed patients with CKD stages 3 and 4 subjected to elective femoral endarterectomy due to established clinical PAD and studied its correlation with different inflammatory markers. The gene discussed is FGF23; the disease is chronic kidney disease.